Back

Usefulness and safety of fasudil, a selective Rho-kinase inhibitor, for PCI-related myocardial ischemia in interventional cardiology

25 August 2018 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Coronary artery disease: revascularisation 1 Revascularisation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Assistant Professor Yoku Kikuchi

Tohoku University, Sendai (Japan)

10 More presentations in this session

Presentation thumbnail
Professor R. Januszek (Krakow, PL)
Abstract
Presentation thumbnail
Doctor G. Quadri (Turin, IT)
Abstract Slides
Presentation thumbnail
Doctor H. Mehrad (Tabriz, IR)
Presentation thumbnail
Mr B. Oliveira Pedreira (Salvador, BR)
Abstract Slides
Presentation thumbnail
Doctor A. Basuoni (Muscat, OM)

Access the full session

Session thumbnail
Poster Session 1 - Coronary artery disease: revascularisation 1

The Event

Event poster

ESC Congress 2018

25 August 2018 11:00 CET
You may be interested in
thumbnail
Congress Presentation
The selective Rho Kinase 2 inhibitor Chroman-1, is a potent vasodilator but does not compromise left ventricular function in-vivo
25 August 2023
thumbnail
Webinar
Devices and tools in percutaneous coronary interventions - IC Core Curriculum 4
14 September 2022
thumbnail
Congress Presentation
Efficacy and safety of local intracoronary drug delivery in the distal coronary bed as treatment of no-reflow phenomenon during percutaneous coronary intervention
27 August 2021
thumbnail
Congress Presentation
Inhibition of fractalkine signalling reduces intramyocardial haemorrhage and left ventricular thrombus in patients with acute myocardial infarction by modulating immunothrombosis (The FRACTAL trial)
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources